NCT05558956View on ClinicalTrials.gov

Total Body PET-CT Imaging of Prostate Cancer Using Illuccix

EARLY_PHASE1UnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Metastatic Castration-resistant Prostate Cancer
Interventions
DRUG

illuccix 68Ga-PSMA-11 Total Body PET-CT

Illuccix (kit for the preparation of gallium Ga 68 gozetotide injection) 68Ga-PSMA-11

Trial Locations (1)

49503

RECRUITING

BAMF Health, Grand Rapids

Sponsors

Lead Sponsor

BAMF Health
All Listed Sponsors
collaborator

Telix Pharmaceuticals (Innovations) Pty Limited

INDUSTRY

lead

BAMF Health

OTHER